FasterCapital backs Japar Method to transform hypertension management via telehealth
Caracas, Venezuela & Dubai, UAE - Sep 16, 2025
Japar Method and FasterCapital announce a strategic partnership through the EquityPilot program to accelerate deployment of JAPAR’s one-month telemedicine hypertension program in the U.S. and global markets, leveraging FasterCapital’s funding, go-to-market support and product acceleration.
Market Opportunity & Problem Statement
Hypertension affects more than 1.13 billion people worldwide and remains poorly controlled, creating major cardiovascular risk and a global economic burden exceeding hundreds of billions annually. Fragmented care, low adherence, and limited continuous monitoring create a white space for specialized, scalable telehealth solutions focused exclusively on blood pressure management amid rapid telemedicine growth.
Startup Solution & Differentiation
The JAPAR Method is a one-month, evidence-based telemedicine package combining patient education, motivational gamification, psychological counseling, wearable-enabled BP diagnostics, and physician-led personalized treatment via AI-driven algorithms. Priced as a subscription, JAPAR focuses on adherence and clinical outcomes rather than one-off consultations. Early pilot metrics show high engagement and promising retention, supported by the clinical leadership of founder Dr. José Aparicio and a multidisciplinary advisory team.
FasterCapital Partnership Value
Selected into FasterCapital’s EquityPilot cohort, JAPAR gains product development resources, investor introductions, mentoring, and targeted go-to-market execution. FasterCapital (https://www.fastercapital.com) applies rigorous selection criteria—market traction, defensible IP, and scalable unit economics—validating JAPAR’s market fit. The partnership will fund AI enhancements, regulatory readiness, and U.S. market entry with a focused timeline to scale subscribers and secure payer partnerships.
Executive Quotes
“Hesham Zreik: “We invest where vertical specialization meets scalable tech. JAPAR addresses a massive unmet need with a clinically rigorous model and strong founder leadership—ideal for EquityPilot acceleration.”
Dr. José Aparicio, CEO: “Partnering with FasterCapital accelerates our mission to make high-quality hypertension care accessible. With their support we’ll expand AI personalization, secure payer collaborations, and rapidly bring JAPAR’s outcomes-driven program to patients globally.””
Growth Trajectory & Future Plans
Near-term milestones include a Q1 2026 beta, U.S. launch in Q3 2026 targeting 20,000 subscribers by Year 3, and European expansion in Year 4. Funding needs: $1.5M to scale technology, marketing, and regulatory compliance. Longer-term vision: integrate anonymized analytics for population health and license insights for research.
About JAPAR Method
JAPAR Method is a telemedicine startup founded by Dr. José Aparicio to deliver a one-month, clinically driven hypertension management program combining education, counseling, wearable diagnostics, and AI-personalized treatment to improve BP control and patient outcomes.
About FasterCapital
FasterCapital is an early-stage accelerator and venture studio that funds and scales technology startups via programs like EquityPilot, providing product, fundraising and market access support globally. FasterCapital partners with founders to build defensible startups and accelerate commercialization.